©The Author(s) 2022.
World J Clin Cases. Apr 26, 2022; 10(12): 3698-3708
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3698
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3698
Table 7 Multivariate analysis of the prognosis of triple-negative breast cancer
| Factors | SE | Walds | P value | RR (95%CI) | |
| TNM staging | 0.454 | 0.102 | 19.811 | 0.000 | 1.575 (1.289-1.923) |
| Degree of differentiation | 0.322 | 0.104 | 9.586 | 0.000 | 1.380 (1.125-1.692) |
| Lymph node metastasis | 0.312 | 0.112 | 7.760 | 0.000 | 1.366 (1.097-1.702) |
| KPNA2 | 0.360 | 0.121 | 8.852 | 0.000 | 1.433 (1.131-1.817) |
| SOX2 | 0.344 | 0.132 | 6.792 | 0.000 | 1.411 (1.089-1.827) |
| Chemotherapy regimens | -0.543 | 0.142 | 14.623 | 0.000 | 0.581 (0.440-0.767) |
- Citation: Ding F, Chen RY, Hou J, Guo J, Dong TY. Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer. World J Clin Cases 2022; 10(12): 3698-3708
- URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3698.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3698